Drug intelligence / Profile preview

thymulin

Development stage
Preclinical
Modality
Peptides
Administration
Subcutaneous, Intramuscular, Intravenous
01

Overview

Thymulin is a thymic nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) that requires the presence of zinc for its biological activity. Produced by thymic epithelial cells, it plays a critical role in the immune system by inducing T-cell differentiation and enhancing the functions of T-cells and natural killer (NK) cells. Beyond its immunomodulatory role, thymulin exhibits potent anti-inflammatory and neuroprotective properties. It has been shown to inhibit the NF-κB and MAPK signaling pathways, reduce the expression of Toll-like receptor 4 (TLR4) and heat shock proteins (Hsp72, Hsp90), and alleviate pro-inflammatory cytokine production. Research has explored its potential in treating sepsis, chronic inflammation, and autoimmune conditions, with recent studies investigating nanoparticle-bound formulations to improve efficacy and delivery.

Other names
Facteur thymique sériqueSerum thymic factorZinc-thymulinThymic factor
02

Targets

PRKCQ (Protein kinase C theta)TLR4 (Toll-like receptor 4)NF-κB

Beyond the preview

Go deeper on thymulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thymulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call